arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

MeiraGTx Holdings plc

MGTX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$9.29
▼ -5.7% Today
as of Oct 23, 10:49 ET
Last 30 days -27.83% Sep 14 → Oct 23
$8.96 $10.11 $11.26 $12.42 $13.57 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$9.80
High
$10.06
Low
$9.69
Volume
$471,921
Avg Vol
$716,753
Mkt Cap
$1.0B
P/E (TTM)
17.85
Beta
—
52w High
$15.35
52w Low
$6.62
Div Yield
—
Shares Out
$94M

Recent Press Releases & News last 60 days · 3 items

Oct 21 · 08:04 MT Newswires
Meiragtx Holdings Insider Sold Shares Worth $557,200, According to a Recent SEC Filing
Sep 24 · 10:47 MT Newswires
Goldman Sachs Initiates MeiraGTx at Neutral With $16 Price Target
Sep 23 · 12:00 PR GlobeNewswire
MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors

MGTX earnings at a glance

The options market is pricing a move of about ±49.5% after the report, a range of roughly $4.69 to $13.89 from today's $9.29. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±4.3% on average; after the most recent report on May 14, 2026 it moved -0.2%. That means options currently expect more movement than MGTX has typically delivered. MGTX beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 419%. The share price of $9.29 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$6.62
$15
31% of range
Avg surprise (last 4)
-20.8%
Avg reaction (last 2)
-4.3%
0% positive
Latest IV / EM
419%
EM ±49.5% · $10 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.76$-0.14$0.47$1.09$1.71 Actual $-0.62Actual $-0.53Actual $-0.74Actual $-0.32Actual $-0.76Actual $-0.55Actual $-0.51Est $-0.38Actual $-0.48Est $-0.52Actual $-0.62Est $-0.50Actual $-0.57Est $-0.43Actual $1.71 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-51M$46M$143M$241M$338M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.71 — — — — financials
Thu May 14, 2026Mar/2026 $-0.57 $-0.43 -32.6% -11.8% -0.2% earnings
Thu Nov 13, 2025Sep/2025 $-0.62 $-0.50 -24.0% — — earnings
Thu Aug 14, 2025Jun/2025 $-0.48 $-0.52 +7.7% — — earnings
Tue May 13, 2025Mar/2025 $-0.51 $-0.38 -34.2% — -8.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.55 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.76 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.32 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.74 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.53 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.62 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$321M$293,000—$410,000$4M$2M—$11M
Cost of revenue————————
Gross profit————————
Operating income$244M$-41M—$-46M$-45M$-42M—$-40M
Net income$161M$-46M—$-51M$-39M$-40M—$-39M
EPS (diluted)$1.71$-0.57—$-0.62$-0.48$-0.51—$-0.55

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$143M$72M$66M$15M$32M$67M$104M$123M
Inventory————$314,000$607,000$385,000—
Total current assets$218M$96M$92M$34M$47M$80M$124M$139M
Total assets$396M$245M$244M$189M$199M$224M$270M$299M
Long-term debt————————
Total liabilities$181M$303M$250M$230M$196M$191M$202M$204M
Total equity$216M$-58M$-6M$-41M$3M$33M$68M$96M

Implied volatility — last 90 days

29%126%224%321%419% Jun 08 — IV 29% · EM ±3.9%Jun 12 — IV 51% · EM ±5.2%Jun 19 — IV 128% · EM ±28.3%Jun 22 — IV 121% · EM ±25.3%Jun 23 — IV 64% · EM ±13.1%Jun 25 — IV 221% · EM ±43.4%Jun 29 — IV 54% · EM ±9.6%Jun 30 — IV 138% · EM ±23.7%Jul 01 — IV 152% · EM ±25.4%Jul 02 — IV 133% · EM ±21.5%Jul 03 — IV 138% · EM ±21.6%Jul 07 — IV 54% · EM ±7.2%Jul 08 — IV 188% · EM ±23.5%Jul 10 — IV 206% · EM ±22.8%Jul 21 — IV 72% · EM ±16.8%Jul 22 — IV 180% · EM ±41.1%Jul 23 — IV 187% · EM ±42.1%Jul 24 — IV 192% · EM ±42.5%Jul 27 — IV 199% · EM ±41.5%Jul 28 — IV 209% · EM ±42.7%Jul 29 — IV 215% · EM ±43.0%Jul 30 — IV 213% · EM ±41.7%Aug 03 — IV 238% · EM ±42.1%Aug 04 — IV 236% · EM ±40.7%Aug 05 — IV 242% · EM ±40.4%Aug 06 — IV 250% · EM ±40.5%Aug 11 — IV 287% · EM ±37.9%Aug 13 — IV 327% · EM ±38.7%Aug 14 — IV 191% · EM ±21.1%Aug 19 — IV 204% · EM ±12.0%Aug 24 — IV 133% · EM ±27.8%Aug 25 — IV 126% · EM ±25.8%Aug 27 — IV 183% · EM ±35.9%Aug 28 — IV 138% · EM ±26.4%Aug 31 — IV 135% · EM ±23.9%Sep 01 — IV 120% · EM ±20.6%Sep 08 — IV 280% · EM ±37.0%Sep 09 — IV 307% · EM ±38.5%Sep 10 — IV 329% · EM ±38.9%Sep 11 — IV 354% · EM ±39.2%Sep 23 — IV 198% · EM ±39.6%Sep 24 — IV 252% · EM ±49.3%Sep 25 — IV 256% · EM ±49.1%Sep 28 — IV 145% · EM ±25.7%Sep 29 — IV 261% · EM ±44.9%Sep 30 — IV 136% · EM ±22.7%Oct 01 — IV 151% · EM ±24.4%Oct 02 — IV 157% · EM ±24.6%Oct 06 — IV 357% · EM ±47.2%Oct 08 — IV 419% · EM ±49.5%

Sector peers

CGEM
Cullinan Therapeutics, Inc.
$1.0B $14.00-6.0%
VOR
Vor Biopharma Inc.
$1.1B $18.16-4.1%
IMTX
Immatics N.V.
$1.1B $7.35-4.4%
GLUE
Monte Rosa Therapeutics, Inc.
$868M $10.65-5.1%
SANA
Sana Biotechnology, Inc.
$814M $2.27-3.4%
REPL
Replimune Group, Inc.
$1.2B $11.81+0.8%

MGTX earnings FAQ

What is MGTX's expected move for earnings?

Options currently price a move of about ±49.5%, or $4.60 per share either way from $9.29.

How does MGTX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.3%, up 0 times and down 2 times.

What is MGTX's implied volatility?

MGTX's at-the-money implied volatility is about 419% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in